Charles Sternberg, Assistant Editor05.07.21
Nu Skin Enterprises Inc. reported record first-quarter 2021 revenue of $677.0 million, an increase of 31% year over year.
"We are very pleased with a strong start to 2021 with our highest-ever first quarter revenue and earnings per share," said Ritch Wood, chief executive officer. "Our innovative beauty and wellness product initiatives powered by our social commerce business model led to 34 percent growth in our customer base over the prior year and a 22 percent increase in global sales leaders.”
The West markets continued to lead in adopting the brand’s social commerce business model with triple-digit growth. In the East, Nu Skin grew 14 percent in Japan and modestly in Mainland China and anticipates increased adoption of its social commerce strategy and digital tools.
Wood forecasts strong demand for new product innovations being introduced in the back half of the year. These include Beauty Focus Collagen+, which is the first product in a new beauty-from-within line, and ageLOC Meta, a metabolic health supplement and our next major Pharmanex product introduction.
"We are very pleased with a strong start to 2021 with our highest-ever first quarter revenue and earnings per share," said Ritch Wood, chief executive officer. "Our innovative beauty and wellness product initiatives powered by our social commerce business model led to 34 percent growth in our customer base over the prior year and a 22 percent increase in global sales leaders.”
The West markets continued to lead in adopting the brand’s social commerce business model with triple-digit growth. In the East, Nu Skin grew 14 percent in Japan and modestly in Mainland China and anticipates increased adoption of its social commerce strategy and digital tools.
Wood forecasts strong demand for new product innovations being introduced in the back half of the year. These include Beauty Focus Collagen+, which is the first product in a new beauty-from-within line, and ageLOC Meta, a metabolic health supplement and our next major Pharmanex product introduction.